Research Highlight | Published:

PROSTATE CANCER

Efficacy of a PSMA-targeted nanoparticle

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

    Original article

    1. Autio, K. A. et al. Safety and efficacy of BIND-014, a docetaxel nanoparticle targeting prostate-specific membrane antigen for patients with metastatic castration-resistant prostate cancer. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2018.2168 (2018)

    Download references

    Author information

    Correspondence to Conor A. Bradley.

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark